In a T2DM rat model induced by STZ and nicotinamide, EGCG treatment improved insulin levels and significantly reduced blood glucose, glycated hemoglobin, insulin resistance index, and lipid profile levels. Here, INS is linked to type 2 diabetes mellitus.